Unilever PLC (LON:ULVR – Get Free Report) has earned an average recommendation of “Reduce” from the six research firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 3,821.32.
A number of brokerages have recently issued reports on ULVR. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 5,150 price target on shares of Unilever in a research report on Wednesday, May 6th. Jefferies Financial Group restated an “underperform” rating and issued a GBX 3,700 price target on shares of Unilever in a research report on Wednesday, May 27th. Berenberg Bank boosted their price target on shares of Unilever from GBX 50.40 to GBX 57.90 and gave the stock a “hold” rating in a research report on Friday, May 1st. Finally, Royal Bank Of Canada upgraded shares of Unilever to a “sector perform” rating and set a GBX 4,200 price target on the stock in a research report on Tuesday, April 21st.
Get Our Latest Research Report on ULVR
Unilever Stock Down 0.9%
Unilever Company Profile
The world’s best‑known brands, creating Desire at Scale.
Unilever employed approximately 116,000 people in 2025 and generated €50.5 billion in turnover for the year. We have around 400 brands found in homes all over the world, with many iconic names including Dove, Hellmann’s, Knorr, OMO and Surf. We create culturally connected brands. Connecting with people where and how it matters to them, pioneering change, defining the future and delivering impact.
Our vision is to be the global leader in sustainable business, market-making, culture-creating, future-shaping.
Further Reading
- Five stocks we like better than Unilever
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Unilever Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilever and related companies with MarketBeat.com's FREE daily email newsletter.
